[Notable adverse events of ALK inhibitors in patients with ALK rearranged non-small-cell lung cancer]

MeSH terms

• Anaplastic Lymphoma Kinase
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Drug Design
• Humans
• Lung Neoplasms / drug therapy*
• Molecular Targeted Therapy
• Protein Kinase Inhibitors / adverse effects*
• Protein Kinase Inhibitors / therapeutic use
• Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*